Mustafa Aksoy

Mustafa Aksoy

Auto-generated profile, based on publicly available information

Mustafa Aksoy

Dünyagöz Hospital, İzmir, Türkiye

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2021 in Eye & Contact Lens: Science & Clinical Practice
Verified
Journal Article
Closed access
MAMustafa Aksoy
Mustafa Aksoy
MSMert M.D. Simsek
Mert M.D. Simsek
Objective: This study aimed to investigate the ocular surface and symptoms of dry eye in individuals who wear face masks on a daily basis. Methods: This prospective study evaluated 52 right eyes of 52 subjects (26 men, 26 women) who routinely wore face masks for at least 8 hrs a day. Mean age was 30.48±6.01 years. All patients were assessed with Schirmer-1 test, Tear Break-up Time (TBUT), Oxford staining grade, and Ocular Surface Disease Index (OSDI) at initial clinical admission (T1), after 8 hrs of face mask use (T2), and after 15 days of greater than 8 hrs daily wear of face masks with the open portions of the mask taped down (T3). Results: Mean TBUT was 13.03±2.18 seconds(s) at T1, 9.12±1.85 sec at T2, and 12.78±2.05 sec at T3. Mean Schirmer-1 test results were 16.87±3.01 mm at T1, 12.97±2.74 mm at T2, and 17.01±2.95 mm at T3. There was a significant difference between T1 and T2, and between T2 and T3 in TBUT (P<0.001), Schirmer-1 results (P<0.001), and Oxford staining grade (P=0.030, P=0.003, respectively). There was a significant difference between all examination times in OSDI score (P<0.001). Conclusion: Improper use of face masks may cause increased ocular irritation and dry eye symptoms. Taping down the upper portion of the face mask blocks exhaled air from directly entering the eyes, preventing potential symptoms of dry eye.

17 November 2020 in Current Eye Research
Verified
Journal Article
Closed access
MAMustafa Aksoy
Mustafa Aksoy
MSMert Simsek
Mert Simsek
MAMahmut Apaydın
Mahmut Apaydın
Purpose: This study aims to assess choroidal vascularity index (CVI) and choroidal thickness (CT) in patients diagnosed with type 1 diabetes mellitus (DM) and compare them with healthy control subjects. Methods: This retrospective and cross-sectional study includes 43 patients diagnosed with type 1 DM and 43 healthy age/gender-matched subjects as the control group. Enhanced depth imaging optical coherence tomography (EDI-OCT; Spectralis, Heidelberg Engineering GmbH, Heidelberg, Germany) images of all participants were analyzed. CT measurements of five different points (subfoveal, 500 µm temporal, 1500 µm temporal, 500 µm nasal, and 1500 µm nasal to the fovea) were obtained. Choroid images were divided into luminal (LA) and stromal areas (SA) determined by image binarization method. Choroidal vascularity index (CVI) was defined as the ratio of LA to total choroid area (TCA). The effects of age, HbA1c, fasting plasma glucose, duration of DM, mean blood pressure, intraocular pressure, and axial length measurements on CVI were investigated. Results: There was no significant difference between any of the CT measurements of the groups (all p > .05). There was no significant difference between the groups according to TCA (0.82 ± 0.24 vs. 0.80 ± 0.19; p = .065), LA (0.54 ± 0.17 vs. 0.55 ± 0.16; p = .123) and SA (0.28 ± 0.06 vs. 0.25 ± 0.07; p = .068). However, patients had significantly lower CVI compared to control subjects (66.07 ± 3.19 vs. 68.89 ± 2.85, p < .001). Univariate linear regression model revealed that there was a negative correlation between disease duration and CVI (standardized beta coefficient: -0.416, p = .006). Conclusion: According to our findings, reduced CVI may indicate subclinical dysfunction in choroid of patients with type 1 DM.

1 December 2016 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
SGSirel Gür Güngör
Sirel Gür Güngör
AAAhmet Akman
Ahmet Akman
LALeyla Asena
Leyla Asena
MAMustafa Aksoy
Mustafa Aksoy
ASAlmila Sarıgül Sezenöz
Almila Sarıgül Sezenöz
To compare anterior chamber depth (ACD) changes after phacoemulsification surgery in patients with pseudoexfoliation syndrome (PEX) and normal patients using an anterior segment imaging method. Another aim of this study was to evaluate the effect of these changes on the accuracy of intraocular lens (IOL) power calculation and postoperative refraction. Twenty-two eyes of 22 patients with PEX and 30 eyes of 30 normal patients who underwent uneventful phacoemulsification surgery and IOL implantation were included in the study. The ACD of all patients was evaluated preoperatively and at 3 months postoperatively with the ALLEGRO Oculyzer (WaveLight® Oculyzer™ II, Alcon, Novartis)-Scheimpflug imaging system. The postoperative mean ACD values were significantly larger than the preoperative ACD values in both groups (p<0.001 for both groups). The pre- to postoperative change in ACD was 0.46±0.3 mm in the PEX group, which was a larger change than seen in the normal patients (0.12±0.1 mm) (p=0.04). The mean absolute errors (MAE) calculated with different IOL formulas (SRK/T, Haigis, Hoffer and Holladay 1 formulas) were comparable and no statistically significant difference was observed between the two groups (p=0.21). Phacoemulsification induces more significant ACD changes in patients with PEX compared to normal patients. However, the MAE did not differ significantly between the groups.

4 February 2022 in Eye
Verified
Journal Article
Closed access
PDF file
MSMert Simsek
Mert Simsek
MAMustafa Aksoy
Mustafa Aksoy
RURezan Kocak Ulucakoy
Rezan Kocak Ulucakoy

17 March 2021 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
MAMustafa Aksoy
Mustafa Aksoy
LALeyla Asena
Leyla Asena
SGSirel Gür Güngör
Sirel Gür Güngör
AKAli Küçüködük
Ali Küçüködük
AAAhmet Akman
Ahmet Akman

1 October 2020 in Journal of Ocular Pharmacology and Therapeutics
Verified
Journal Article
Closed access
MAMustafa Aksoy
Mustafa Aksoy
GYGursel Yilmaz
Gursel Yilmaz
IVIrfan Vardarli
Irfan Vardarli
IAImren Akkoyun
Imren Akkoyun
Purpose: This study aims to compare subfoveal choroidal thicknesses (SFCTs) after intravitreal dexamethasone (IVD) or intravitreal aflibercept (IVA) treatment in patients with persistent diabetic macular edema (DME) unresponsive to intravitreal ranibizumab (IVR). Methods: The study consisted of patients with DME unresponsive to IVR treatment in which 37 were administered 1 dose IVD (group A) and 34 patients who were administered 3 doses of IVA (group B), as well as 35 healthy individuals (group C). Detailed ophthalmological examination and optical coherence tomography parameters of group A and group B, including central retinal thickness and SFCT, were retrospectively evaluated before and after treatment. Results from preinjection, and 1, 2, and 3 months after injection were analyzed. Results of group A and group B were compared within themselves and also compared with group C. Results: SFCT measurements were compared within group A and group B (1 = preinjection; 2 = 1 month postinjection; 3 = 2 months postinjection; 4 = 3 months postinjection). There was significant thinning in SFCT between 1–2, 1–3, 1–4, 2–3, 2–4, and 3–4 time intervals within both group A and group B (both P < 0.001). Comparison of SFCT measurements showed preinjection, 1-, and 2-month values of group A were significantly thicker than those of group C ( P < 0.001), whereas there was no significant difference between 3-month values ( P = 0.09). Preinjection, 1-, and 2-month values of group B were significantly thicker than those of group C ( P < 0.001), whereas there was no significant difference between 3-month values ( P = 0.06). Conclusions: Three month follow-up showed thinning in SFCT measurements in patients with persistent DME unresponsive to IVR who were applied IVD or IVA treatment.